Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
B cell immunofocusing and repriming in two HIV-1 Env immunization regimens.
DeLuca JM, Blasi M, Jha S, Shen X, Pollara J, Kerkau M, Purwar M, Carnathan DG, Negri D, Cara A, Wollenberg K, Saunders KO, Lu S, Silvestri G, Weiner DB, Klotman ME, Ferrari G, Moody MA, Bonsignori M. DeLuca JM, et al. Among authors: negri d. Res Sq [Preprint]. 2024 Apr 8:rs.3.rs-3895128. doi: 10.21203/rs.3.rs-3895128/v1. Res Sq. 2024. PMID: 38659814 Free PMC article. Preprint.
Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles.
Borghi M, Gallinaro A, Pirillo MF, Canitano A, Michelini Z, De Angelis ML, Cecchetti S, Tinari A, Falce C, Mariotti S, Capocefalo A, Chiantore MV, Iacobino A, Di Virgilio A, van Gils MJ, Sanders RW, Lo Presti A, Nisini R, Negri D, Cara A. Borghi M, et al. Among authors: negri d. Front Immunol. 2023 Apr 5;14:1147953. doi: 10.3389/fimmu.2023.1147953. eCollection 2023. Front Immunol. 2023. PMID: 37090707 Free PMC article.
New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis.
Mariotti S, Chiantore MV, Teloni R, Iacobino A, Capocefalo A, Michelini Z, Borghi M, Baggieri M, Marchi A, Bucci P, Gioacchini S, D'Amelio R, Brouwer PJM, Sandini S, Acchioni C, Sgarbanti M, Di Virgilio A, Grasso F, Cara A, Negri D, Magurano F, Di Bonito P, Nisini R. Mariotti S, et al. Among authors: negri d. Biomedicines. 2023 Feb 18;11(2):610. doi: 10.3390/biomedicines11020610. Biomedicines. 2023. PMID: 36831149 Free PMC article.
Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers.
Gallinaro A, Pirillo MF, Aldon Y, Cecchetti S, Michelini Z, Tinari A, Borghi M, Canitano A, McKay PF, Bona R, Vescio MF, Grasso F, Blasi M, Baroncelli S, Scarlatti G, LaBranche C, Montefiori D, Klotman ME, Sanders RW, Shattock RJ, Negri D, Cara A. Gallinaro A, et al. Among authors: negri d. NPJ Vaccines. 2022 Apr 21;7(1):44. doi: 10.1038/s41541-022-00465-1. NPJ Vaccines. 2022. PMID: 35449174 Free PMC article.
Seasonal Betacoronavirus Antibodies' Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization.
Dispinseri S, Marzinotto I, Brigatti C, Pirillo MF, Tolazzi M, Bazzigaluppi E, Canitano A, Borghi M, Gallinaro A, Caccia R, Vercesi R, McKay PF, Ciceri F, Piemonti L, Negri D, Cinque P, Cara A, Scarlatti G, Lampasona V. Dispinseri S, et al. Among authors: negri d. J Clin Immunol. 2022 Apr;42(3):448-458. doi: 10.1007/s10875-021-01190-5. Epub 2022 Jan 9. J Clin Immunol. 2022. PMID: 35000058 Free PMC article.
Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency.
Mariotti S, Capocefalo A, Chiantore MV, Iacobino A, Teloni R, De Angelis ML, Gallinaro A, Pirillo MF, Borghi M, Canitano A, Michelini Z, Baggieri M, Marchi A, Bucci P, McKay PF, Acchioni C, Sandini S, Sgarbanti M, Tosini F, Di Virgilio A, Venturi G, Marino F, Esposito V, Di Bonito P, Magurano F, Cara A, Negri D, Nisini R. Mariotti S, et al. Among authors: negri d. Front Immunol. 2021 Oct 26;12:750386. doi: 10.3389/fimmu.2021.750386. eCollection 2021. Front Immunol. 2021. PMID: 34764961 Free PMC article.
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.
Dispinseri S, Secchi M, Pirillo MF, Tolazzi M, Borghi M, Brigatti C, De Angelis ML, Baratella M, Bazzigaluppi E, Venturi G, Sironi F, Canitano A, Marzinotto I, Tresoldi C, Ciceri F, Piemonti L, Negri D, Cara A, Lampasona V, Scarlatti G. Dispinseri S, et al. Among authors: negri d. Nat Commun. 2021 May 11;12(1):2670. doi: 10.1038/s41467-021-22958-8. Nat Commun. 2021. PMID: 33976165 Free PMC article.
Anticancer Effects of Sublingual Type I IFN in Combination with Chemotherapy in Implantable and Spontaneous Tumor Models.
Ciccolella M, Andreone S, Mancini J, Sestili P, Negri D, Pacca AM, D'Urso MT, Macchia D, Canese R, Pang K, SaiYing Ko T, Decadt Y, Schiavoni G, Mattei F, Belardelli F, Aricò E, Bracci L. Ciccolella M, et al. Among authors: negri d. Cells. 2021 Apr 8;10(4):845. doi: 10.3390/cells10040845. Cells. 2021. PMID: 33917958 Free PMC article.
86 results